Patrick Page
26Patents
8h-index
24Co-inventors
71Inventor score
Filing activity: Jun 14, 2002 → Jan 27, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8389518B2 | Pyrazolo pyridine derivatives as NADPH oxidase inhibitors | Human Necessities | 13 | Active |
| US8796280B2 | 2,3-disubstituted pyrazinesulfonamides as CRTH2 inhibitors | Chemistry; Metallurgy | 11 | Expired |
| US8288432B2 | Tetrahydroindole derivatives as NADPH oxidase inhibitors | Emerging Cross-Sectional Technologies | 10 | Active |
| US8865758B2 | Pyrazolo piperidine derivatives as NADPH oxidase inhibitors | Human Necessities | 10 | Active |
| US8455485B2 | Pyrazolo pyridine derivatives as NADPH oxidase inhibitors | Emerging Cross-Sectional Technologies | 9 | Active |
| US8748456B2 | Pyrazolo piperidine derivatives as NADPH oxidase inhibitors | Human Necessities | 9 | Active |
| US8481562B2 | Pyrazolo pyridine derivatives as NADPH oxidase inhibitors | Human Necessities | 9 | Active |
| US8455486B2 | Pyrazolo pyridine derivatives as NADPH oxidase inhibitors | Emerging Cross-Sectional Technologies | 9 | Active |
| US7115639B2 | Pyrrolidine oxadiazole- and thiadiazole oxime derivatives being oxytocin receptor antagonists | Chemistry; Metallurgy | 8 | Expired |
| US8404690B2 | Piperazine-2-carboxamide derivatives | Chemistry; Metallurgy | 8 | Active |
| US8415480B2 | Thiazolidine carboxamide derivatives as modulators of the prostaglandin F receptor | Emerging Cross-Sectional Technologies | 6 | Active |
| US8940760B2 | Pyrazolo pyridine derivatives as NADPH oxidase inhibitors | Human Necessities | 5 | Active |
| US9447055B1 | α-amino esters of hydroxypropylthiazolidine carboxamide derivative and salt form, crystal polymorph thereof | Chemistry; Metallurgy | 5 | Active |
| US8236963B2 | Tricyclic spiro derivatives as CRTH2 modulators | Human Necessities | 5 | Active |
| US9012449B2 | Pyrazolo pyridine derivatives as NADPH oxidase inhibitors | Emerging Cross-Sectional Technologies | 4 | Active |
| US9006238B2 | Pyrazolo pyridine derivatives as NADPH oxidase inhibitors | Emerging Cross-Sectional Technologies | 4 | Active |
| US10259795B2 | Alpha-amino esters of hydroxypropylthiazolidine carboxamide derivative and salt form, crystal polymorph thereof | Chemistry; Metallurgy | 4 | Active |
| US9834528B2 | Alpha-amino esters of hydroxypropylthiazolidine carboxamide derivative and salt form, crystal polymorph thereof | Chemistry; Metallurgy | 4 | Active |
| US9073919B2 | Pyrazolo pyridine derivatives as NADPH oxidase inhibitors | Human Necessities | 4 | Active |
| US10555934B2 | Alpha-amino esters of hydroxypropylthiazolidine carboxamide derivative and salt form, crystal polymorph thereof | Human Necessities | 2 | Active |
| US9394306B2 | Pyrazoline dione derivatives as NADPH oxidase inhibitors | Chemistry; Metallurgy | 1 | Active |
| US10772891B2 | Pyrazolo pyridine derivatives as NADPH oxidase inhibitors | Emerging Cross-Sectional Technologies | 1 | Active |
| US9974791B2 | Pyrazolo pyridine derivatives as NADPH oxidase inhibitors | Emerging Cross-Sectional Technologies | 1 | Active |
| US9096588B2 | Pyrazolo pyridine derivatives as NADPH oxidase inhibitors | Emerging Cross-Sectional Technologies | 1 | Active |
| US11524003B2 | Alpha-amino esters of hydroxypropylthiazolidine carboxamide derivative and salt form, crystal polymorph thereof | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.